Description
lobal minimal residual disease testing market size is expected at $2.32 Bn by 2027 at a growth rate of 13.3%.
RAW Paste Data
Recent Pastes
-
⌛ December 8th Update Notes
Plaintext | 4 | 2 minutes ago
-
đá
Plaintext | 5 | 13 minutes ago